💡 How to invest and swing trade using Tenet Research 4 Pillar Methodology : Webinar is Up for those who missed. I walk through the exact process behind a 194% & 65% Portfolio Growth with timestamped Case Studies Same strategies. Same platform. Watch the full breakdown.

$BE $DELL Top Day Trades today Gave both setups in morning Tweet how to long! Ripster 1 HR MTF Clouds Are Cheat Code I show everyday Checkout Long/Stops/Targets in Live Guidance below

This

$VKTX Read the full post **“Number two most widely used bear theories on X: ‘LLY dominates obesity.’ ‘No room for late entrants.’ Both are null thesis. See the picture below Look at statins — the classic example. One drug dominated, but multiple late entrants still became blockbusters over time. The market wasn’t ‘crowded,’ it was stratified. Clinical strength determined winners, not timing. Obesity will behave like Statins: the best drugs take share, late entrants with superior drug profiles still become multi-billion franchises. Here's a classic snapshot of Statins usage and blockbuster status over time. There were roughly 5+ statins approved over time. Here's the timeline. 1) Lovastatin was approved in 1987 (Merck) 2) Pravastatin was approved in 1987 (Bristol-Myers) 3) Simvastatin was approved in 1991 (Merck) 4) Lipitor was approved in 1997 (Pfizer). Ten years after the first statin was approved and became the most successful drug for Pfizer even it came to the market so late. 5) Crestor was approved in 2003 (AstraZeneca). It became another blockbuster drug despite getting to the market after so many drugs already competing for the same crowded space.

$BE Becoming one of our Biggest Winners of the year right there with $BULL $HOOD $SKHY $CRDO If you followed my Analysis all this year you should be riding as well! Fundamentals Tell You what to buy Technicals Tell You when ALL LIVE TRANSPARENT Portfolio at @tenetresearch

$COST $MSFT $BE $DELL some best movers from our daily plan! Everything is rule based We trade what we plan with Cloud System! Checkout how these worked out

$CRDO Longs like this is what takes your account Parabolic! Position now up 37% Also shared the chart setup vs 150 Psych | Never hindsight! Great win for @tenet_research Investors

$DELL 💡 We added yesterday 530 today its up 30 bucks That is power of Daily 20/21 Ripster MTF and this morning 1 HR MTF breakout or your Daily 20/21 EMAs

💡Al Jazeera says Iran US Talks enter a technical stage market pop $SPY $QQQ

$SPY $QQQ Yet again 10:40 Algo came to save the market I Often talk about 10:40 Algo 2nd time this week

$UNH $OSCR $CI Healthcare Insurance popped on our rotation sector today Lot of strength today in this sector $OSCR good name

$VKTX Maintenance study slides up chart 1 Large induction weight loss through week 21 with no plateau with the curve keeps trending downwards. Significance of this chart- Up to ~ 19% weight loss with n=118 This is giving you an estimate of how phase 3 curve will look like if you extend over 52+ weeks. 17.5mg will be the phase 3 best tolerability and commercial dose. This is biggest phase 3 signal that with no plateau in sight; early curves predict long-term curves. In conclusion, maintenance data de-risked phase 3 and the chart confirms the durability and safety signals are much cleaner.

$MSFT Going bonkers from 500 Psych , Satya trying to compete with MUSE, hence the beautiful move!

$CRDO 💡 Gap filled as promised Swing from 150 now up 36%!!!

🚨 Friday Free Trading Gameplan Courtsey @TENETTRADEGROUP $META $TSLA $NVDA $PLTR $RKLB $COIN $DELL $BE $AKAM